Zentalis Pharmaceuticals Inc.

ZNTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.03

-$0.08 (-2.57%)

At close: Sep 21, 2026, 4:00 PM ET

$3.08

+$0.05 (+1.64%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	67.43M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	67.43M	n/a	n/a	n/a	n/a
Operating Income	-152.81M	-191.19M	-299.51M	-227.29M	-216.54M	-118.79M
Interest Income	n/a	n/a	n/a	2.26K	n/a	n/a
Pretax Income	-136.62M	-165.69M	-292.91M	-237.58M	-166.39M	-118.1M
Net Income	-137.06M	-165.84M	-292.19M	-236.81M	-158.73M	-117.84M
Selling & General & Admin	37.72M	87.12M	59.4M	54.55M	40.94M	33.89M
Research & Development	107.3M	167.77M	235.16M	172.73M	175.6M	84.9M
Other Expenses	7.8M	3.74M	4.95M	n/a	n/a	n/a
Operating Expenses	152.81M	258.62M	299.51M	227.29M	216.54M	118.79M
Interest Expense	n/a	n/a	n/a	2.58M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	152.81M	258.62M	299.51M	227.29M	216.54M	118.79M
Income Tax Expense	442K	177K	-601K	-469K	-297K	444K
Shares Outstanding (Basic)	71.87M	71.08M	65.41M	52.86M	42.69M	41.04M
Shares Outstanding (Diluted)	71.87M	71.08M	65.41M	52.86M	42.69M	41.04M
EPS (Basic)	-1.91	-2.33	-4.47	-4.48	-3.72	-2.87
EPS (Diluted)	-1.91	-2.33	-4.47	-4.48	-3.72	-2.87
EBITDA	-144.27M	-186.17M	-247.6M	-233.58M	-207.2M	-118.63M
EBIT	-145.01M	-187.46M	-248.99M	-235.01M	-207.74M	-118.79M
Depreciation & Amortization	739K	1.29M	1.39M	1.43M	544K	160K